Cannabis terpenes, the part of the plant which provides aroma and flavor, may provide therapeutic benefits in controlling pain, a new study reports.
Study reveals high-potency cannabis does not impact decision-making performance but does affect memory in relation to free recall, source memory, and false memories.
A newly developed cannabidiol capsule can be absorbed by the body faster and penetrate the brain more quickly in mouse models of neurological disorders such as Alzheimer's disease, multiple sclerosis and TBI.
A new study in Zebrafish reveals exposure to compounds found in cannabis during the early stages of development was linked to a significant drop in neural activity later in life.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
People with OCD reported a reduction in the symptoms within four hours of smoking cannabis, a new study reports.
Staphylococcal enterotoxin, a bacterial toxin implicated in some ARDS cases, can be prevented by treatment with the cannabis compound THC. Findings also suggest a potential role for using cannabinoids to treat ARDS caused by COVID-19.
Cannabidiol (CBD) increases cerebral blood flow to areas of the brain associated with memory processing, specifically the hippocampus. The findings identify a potential mechanism for the use of CBD to treat disorders associated with altered memory processing, including Alzheimer's disease, PTSD, and schizophrenia.
Cannabis reduces the severity of symptoms by more than half in the short-term for people suffering from PTSD. Using cannabis reduces recurring thoughts of a traumatic event by 62%, flashbacks by 51%, irritability by 67%, and anxiety by 57% for those with PTSD. However, the reduction of symptoms is not permanent.